Тёмный

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management 

Touch Medical Media
Подписаться 7 тыс.
Просмотров 2,9 тыс.
50% 1

The 2022 updates of international guidelines affect diagnosis, classification and management of HR-MDS and AML.
Get up-to-date on their impact on clinical practice with expert perspectives.
Watch now: touchhaematolo...
With Prof. Andrew Wei, Prof. Agnieszka Wierzbowska and Prof. Gert Ossenkoppele.
--------
This activity is supported by an independent medical education grant from Novartis and is provided by touchIME.

Опубликовано:

 

30 сен 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 1   
@amybradley5821
@amybradley5821 8 месяцев назад
Does it really matter as the treatments are mostly the same. I refuse to have a bone marrow aspiration. They are saying MDS but treatment seems the same. I would never consider a BMT so just treat as things come up. For now I have low white and platelets and reds are about to go below normal. I don’t see treatments very different
Далее
MDS transformation to AML
1:00:43
Просмотров 4,1 тыс.
Treatment Update: Myelodysplastic Syndromes (MDS)
1:02:28
Challenges in MDS Diagnosis
24:25
Просмотров 1 тыс.
Clonal Hematopoiesis: Origins and Clinical Implications
1:04:42
Can we do better than HMA in HR-MDS?
21:00
Просмотров 169
WHO Classification of Myelodysplastic Syndromes
55:37
Просмотров 3,3 тыс.